98%
921
2 minutes
20
Contact dermatitis (CD), which includes both allergic CD and irritant CD, is a common inflammatory condition that can pose significant diagnostic challenges. Although patch testing is the gold standard for identifying causative allergens for allergic contact dermatitis (ACD), it is time-consuming, subjective, and requires expert interpretation. Recent advancements in artificial intelligence (AI), particularly in machine learning (ML) and deep learning, have shown promise in improving the accuracy, efficiency, and accessibility of CD diagnosis and management. This review explores current applications of AI in CD, drawing from 12 original studies that investigated AI-based image analysis, biomarker discovery, and patient risk profiling. Convolutional neural networks demonstrated high diagnostic accuracy (up to 99.5%) in interpreting patch test images, while ML algorithms successfully identified transcriptomic signatures distinguishing allergic CD from irritant CD. In addition, AI has been used to predict positive patch test outcomes and identify high-risk patients based on clinical and occupational factors. Despite these promising developments, limitations such as dataset bias, lack of standardization, and model interpretability remain. Nevertheless, AI represents a transformative tool in dermatology, offering the potential for standardized diagnostics, personalized care, and enhanced accessibility.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/17103568251376647 | DOI Listing |
Dermatitis
September 2025
From the Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences (AIIMS), Bhopal, India.
Contact dermatitis (CD), which includes both allergic CD and irritant CD, is a common inflammatory condition that can pose significant diagnostic challenges. Although patch testing is the gold standard for identifying causative allergens for allergic contact dermatitis (ACD), it is time-consuming, subjective, and requires expert interpretation. Recent advancements in artificial intelligence (AI), particularly in machine learning (ML) and deep learning, have shown promise in improving the accuracy, efficiency, and accessibility of CD diagnosis and management.
View Article and Find Full Text PDFContact Dermatitis
September 2025
Department of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Germany.
Background: Nickel and cobalt release from tools has recently been evidenced in German hairdressing salons. Comparable data were not available for German barbershops.
Objectives: Screening of tools for nickel and cobalt release.
J Tissue Viability
September 2025
Swedish Centre for Skin and Wound Research (SCENTR), School of Health Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Skin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Faculty of Medicine a
Background: Incontinence-associated dermatitis (IAD) is a prevalent and distressing form of irritant contact dermatitis caused by prolonged exposure to urine and/or faeces. Not all incontinent individuals develop IAD, suggesting that additional prognostic factors contribute to its onset. The quality of empirical evidence supporting risk factors for IAD development is moderate to very low.
View Article and Find Full Text PDFJ Drugs Dermatol
September 2025
Background: Sunscreens can reduce skin cancer and sunburn. Recent studies on dermal penetration have raised concerns about the safety of sunscreens with organic ultraviolet (UV) filters.
Objective: The aim of the retrospective study was to assess the dermal safety of chemical sunscreens containing the chemical filters avobenzone, octocrylene, homosalate, and octisalate.
Front Immunol
September 2025
Department of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland.
This review presents the current knowledge on the potential of mesenchymal stem cells (MSCs) and their extracellular vesicles (EVs) in the treatment of various skin diseases such as psoriasis, atopic dermatitis, contact dermatitis, systemic sclerosis, graft-versus-host disease, alopecia areata, and systemic lupus erythematosus. MSCs can modulate the immune response and release growth factors and cytokines that promote tissue regeneration and healing and reduce inflammation. In turn, EVs' ability to transport various biological molecules, including microRNAs (miRNAs), makes them potential therapeutic agents.
View Article and Find Full Text PDF